Anticuerpos y Huntington: Diagnosis y tratamiento

La enfermedad de Huntington es un desorden neurodegenerative genético heredado causado por una mutación dominante de un autosoma en el gen del huntingtin dando por resultado una extensión de la repetición del trinucleotide (CAG) con sobre 40 repeticiones.  

Cerebro normal y cerebro con la enfermedad de Huntington, mostrando ventrículos aumentados y la atrofia del tejido de nervio y de ganglios básicos. Haber de imagen: Blamb/Shutterstock

Last Updated: Jan 23, 2019

Osman Shabir

Written by

Osman Shabir

Osman is a Neuroscience PhD Research Student at the University of Sheffield studying the impact of cardiovascular disease and Alzheimer's disease on neurovascular coupling using pre-clinical models and neuroimaging techniques.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Shabir, Osman. (2019, January 23). Anticuerpos y Huntington: Diagnosis y tratamiento. News-Medical. Retrieved on August 24, 2019 from https://www.news-medical.net/health/Antibodies-and-Huntingtons-Diagnosis-Treatment.aspx.

  • MLA

    Shabir, Osman. "Anticuerpos y Huntington: Diagnosis y tratamiento". News-Medical. 24 August 2019. <https://www.news-medical.net/health/Antibodies-and-Huntingtons-Diagnosis-Treatment.aspx>.

  • Chicago

    Shabir, Osman. "Anticuerpos y Huntington: Diagnosis y tratamiento". News-Medical. https://www.news-medical.net/health/Antibodies-and-Huntingtons-Diagnosis-Treatment.aspx. (accessed August 24, 2019).

  • Harvard

    Shabir, Osman. 2019. Anticuerpos y Huntington: Diagnosis y tratamiento. News-Medical, viewed 24 August 2019, https://www.news-medical.net/health/Antibodies-and-Huntingtons-Diagnosis-Treatment.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post